The effectiveness of ribavirin in the treatment of RSV
Cooper, K.E.
Pediatric Nursing 27(1): 95-98
2001
ISSN/ISBN: 0097-9805 PMID: 12025158 Document Number: 539471
Document emailed within 1 workday
Related Documents
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111Khokhar, N. 2002: Effectiveness of 48 weeks Interferon alfa-2b in combination with ribavirin as initial treatment of chronic hepatitis Journal of Ayub Medical College Abbottabad: Jamc 14(3): 5-8
Roberts, R.B.; Dickinson, G.M.; Heseltine, P.N.; Leedom, J.M.; Mansell, P.W.; Rodriguez, S.; Johnson, K.M.; Lubina, J.A.; Makuch, R.W. 1990: A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. the Ribavirin-LAS Collaborative Group Journal of Acquired Immune Deficiency Syndromes 3(9): 884-892
Nunnari, G.; Montineri, A.; Portelli, V.; Savalli, F.; Fatuzzo, F.; Cacopardo, B. 2012: The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C European Review for Medical and Pharmacological Sciences 16(8): 1013-1016
Sánchez-Solís de Querol, M.; Castillo-Ochando, F.; Díaz-Torres, M.; Sayed-Sancho, N.; Sánchez-Flores, F.; Pajarón de Ahumada, M. 1997: Ribavirin in the treatment of bronchiolitis caused by syncytial respiratory virus Anales Espanoles de Pediatria 47(1): 14-16
Varghese, R.; Al-Khaldi, J.; Asker, H.; Fadili, A.A.; Al Ali, J.; Hassan, F.A. 2009: Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin Hepato-Gastroenterology 56(89): 218-222
Taber, L.H.; Knight, V.; Gilbert, B.E.; McClung, H.W.; Wilson, S.Z.; Norton, H.J.; Thurson, J.M.; Gordon, W.H.; Atmar, R.L.; Schlaudt, W.R. 1983: Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants Pediatrics 72(5): 613-618
Guarnieri, A.; Marazzi, F.; Giorgi, M.P.; Canepari, G.; Pino, C.; Moggia, E.; Manca, A.; Ghezzi, P.M. 2002: Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(1): 79-81
Urbánek, P.; Subhanová, I.; Janousová, E.; Dusek, L.; Marecek, Z.; Brůha, R.; Petrtýl, J.; Brodanová, M. 2009: Efficacy of combination treatment with pegylated interferon plus ribavirin in patients chronically infected with HCV Vnitrni Lekarstvi 55(5): 474-479
Yu, J.; Liu, B.-w.; Lan, L.; Yuan, Y.; Zhang, H.; Jia, C.-h. 2010: Efficacy of peginterferon alpha-2a in combination with ribavirin in treatment of eldly patients with chronic hepatitis C Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(5): 373-375
Słuzewski, W.; Kowala-Piaskowska, A.; Wysocki, J.; Figlerowicz, M.; Gorczyca, A.; Halota, W.; Jóźwiak, H.; Mizerski, J.; Mozer-Lisewska, I.; Pawłowska, M.łg.; Rokitka, M.; Strawińska, E.; Szamotulska, K. 2012: Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study Acta Poloniae Pharmaceutica 69(2): 319-326
Abutidze, A.; Bolokadze, N.; Chkhartishvili, N.; Sharvadze, L.; Tsertsvadze, T. 2016: Incidence of Tuberculosis among Hiv/Hcv Co-Infected Patients Receiving Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Georgia Georgian Medical News 252: 10-15
Husa, P.; Husova, L. 2001: Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons Bratislavske Lekarske Listy 102(5): 248-252
Mira, J.é A.; López-Cortés, L.F.; Merino, D.; Arizcorreta-Yarza, A.; Rivero, A.; Collado, A.; Ríos-Villegas, M.ía.J.; González-Serrano, M.; Torres-Tortoso, M.; Macías, J.; Valera-Bestard, B.ár.; Fernández-Fuertes, E.; Girón-González, J.é A.; Lozano, F.; Pineda, J.A. 2007: Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients Antiviral Therapy 12(8): 1225-1235
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Vashakidze, E.; Imnadze, T. 2017: Combined Antiviral Treatment of Hepatitis C Virus Infection with Pegylated Interferon (Peg-Ifn) Α-2a (Pegferon) and Ribavirin (Copegus) in Inmates Georgian Medical News 264: 86-90
Chu, C-Jen.; Wang, Y-Jen.; Hwang, S-Jang.; Lu, R-Hwa.; Chang, F-Young.; Chang, C-Yu.; Yang, Y-Chun.; Lee, S-Dong. 2007: Kinetics of hepatitis C virus RNA load during pegylated interferon plus ribavirin therapy in Treatment-naive Chinese patients Hepato-Gastroenterology 54(75): 866-870
Nawaz, A.; Nazar, H.; Usmanghani, K.; Sheikh, Z.A.; Chishti, M.A.; Ahmad, I. 2016: Ways to manage hepatitis C without cirrhosis: Treatment by comparison of coded eastern medicine hepcinal with interferon alpha 2b and ribavirin Pakistan Journal of Pharmaceutical Sciences 29(3): 919-927
Mozer-Lisewska, I.; Dworacki, G.; Kaczmarek, E.; Słuzewski, W.; Kowala-Piaskowska, A.; Figlerowicz, M.; Kaczmarek, M.; Zeromski, J. 2005: Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin Przeglad Epidemiologiczny 59(2): 483-489
Taskoparan, M.; Serin, E.; Gokturk, H.Savas.; Icer, M.Okan.; Abaci, K.; Ozer, B.; Zumrutdal, A.; Yilmaz, U. 2011: Early effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C Hepato-Gastroenterology 58(107-108): 875-879